n-acetylsphingosine and mk 2206

n-acetylsphingosine has been researched along with mk 2206 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, X; Ding, J; Feng, M; Gao, F; Hu, S; Liu, H; Lu, J; Luo, C; Shi, Y; Wang, J; Xie, Z; Xu, H	1

Other Studies

1 other study(ies) available for n-acetylsphingosine and mk 2206

Article	Year
Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer. European journal of medicinal chemistry, 2021, Apr-05, Volume: 215 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ceramides; Drug Design; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 3-Ring; Humans; Mice, Inbred BALB C; Naphthalenes; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species	2021

Article

Year

Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.

European journal of medicinal chemistry, 2021, Apr-05, Volume: 215

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ceramides; Drug Design; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 3-Ring; Humans; Mice, Inbred BALB C; Naphthalenes; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species

2021